Arogya Finance and DRL collaborate to provide medical loans for financially weak

Arogya Finance and DRL collaborate to provide medical loans for financially weak

Facilitates medical loans for Resof, a drug for treatment of Hepatitis C virus (HCV) infection and a few other therapies

Arogya Finance has tied up with Dr Reddy’s Laboratories for providing medical loans for treatment of Hepatitis C. Reportedly, Arogya Finance will facilitate easy Equated Monthly Installments to patients to pay for the drug for Hepatitis C and a few other therapies provided by Dr Reddy’s Laboratories.

Arogya Finance does not require collaterals or formal income proof which is mandatory in other forms of finance. A company release informs that Arogya Finance offers a loan and makes it easily available within 24 hours. The company offers medical loans to the traditionally unbankable, using a psychometric test as a risk assessment tool to enable evaluation of the credit risk profile of people outside the formal banking system. The borrowers can repay the loans in EMIs of upto 36 months and is calculated in a way that it does not exceed 25 per cent of the total family income.